Syncona Partners LLP Overview
Syncona Limited is a healthcare company focused on investing in and building global leaders in life sciences. They create, build, and scale companies to transform exceptional science into transformational treatments for patients in areas of high unmet need. Their strategy is underpinned by their balance sheet, enabling a long-term view to improve patient lives, build sustainable life science companies, and deliver strong risk-adjusted returns to shareholders.
Is Syncona Partners LLP the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Syncona Partners LLP, along with a list of other relevant VCs, is available on Hopohopo.io.
Syncona Partners LLP
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
Investment role
Lead and follow
Stages
Series A
First ticket size
£35,000,000 - £87,000,000
Contact information
Head of People
Harriet Isaac
How to approach funds like Syncona Partners LLP
When engaging Syncona, founders should highlight the scientific rigor and clinical potential of their technology, especially if addressing significant unmet medical needs. Demonstrate a clear path from foundational science to patient impact, and be prepared to discuss long-term development milestones. Syncona values teams with deep domain expertise and a collaborative mindset, as they often take an active role in company building and strategic direction.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
